Stay updated on ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial
Sign up to get notified when there's something new on the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page.

Latest updates to the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe PubMed publication text on the study page was updated to indicate publications are automatically filled from PubMed, and the revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check24 days agoChange DetectedRemoved the government funding status notice that warned about potential delays and directed users to update sources for operating status.SummaryDifference0.2%

- Check46 days agoChange DetectedThe update appears to reflect only minor UI/layout changes with no alterations to core study content (title, BRCA mutation, interventions, outcomes, or eligibility). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check67 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, plus a version bump to v3.2.0. - Removed the old version reference v3.1.0.SummaryDifference2%

- Check74 days agoChange DetectedPage version updated to v3.1.0; removal of the term 'Ovarian cancer'.SummaryDifference0.1%

- Check88 days agoChange DetectedUpdated from v3.0.1 to v3.0.2 and removed the 'Back to Top' element. No other core content or key information appears to have changed.SummaryDifference0.1%

Stay in the know with updates to ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page.